A House committee on Wednesday passed a bill to renew a program aimed at aiding development of drugs for rare diseases in ...

A House committee on Wednesday advanced legislation that would extend Medicare telehealth flexibilities and a home hospital ...

In the months after the retraction, Chris Ferguson, a psychologist at Stetson University and an editor at a different ...

Sen. Bernie Sanders has been probing the high prices that Novo charges for Ozempic and Wegovy. Yesterday, he share that ...

A long-running race to develop a gene therapy for the most common cause of age-related blindness is heating up. On Wednesday, ...

A rival CEO's confrontational social media post underscored the high stakes in the race to develop and deploy cancer ...

DEHP, a cancer-causing chemical, is widely present in IV devices used to treat cancer. California is poised to take action, ...

Some drugmakers' submission of multiple "use codes" to expand patent claims appears to be delaying the arrival of lower-cost ...

The process for translating clinical trial results into action for young women in Africa has been left to our imaginations, ...

It’s unclear what kind of system Vance was envisioning, and Trump’s platform doesn’t actually mention the ACA at all. The confusion has provided Democrats with a new line of attack, STAT’s John ...

Democrats are pursuing new attack lines ahead of an election that many see as a referendum on reproductive rights.

Atrium Health’s decision to hold out paid off. As part of the state’s new Medicaid expansion, North Carolina will instead ...